DSNKY (Daiichinkyo Co) COGS-to-Revenue : 0.18 (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Daiichinkyo Co COGS-to-Revenue?

Daiichinkyo Co's Cost of Goods Sold for the three months ended in Mar. 2025 was $633 Mil. Its Revenue for the three months ended in Mar. 2025 was $3,480 Mil.

Daiichinkyo Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.18.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Daiichinkyo Co's Gross Margin % for the three months ended in Mar. 2025 was 81.81%.

Daiichinkyo Co COGS-to-Revenue Historical Data

The historical data trend for Daiichinkyo Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co COGS-to-Revenue Chart

Daiichinkyo Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

COGS-to-Revenue

Get a 7-Day Free Trial

0.35

0.34

0.28

0.26

0.22

Daiichinkyo Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.24	0.22	0.22	0.26	0.18

Daiichinkyo Co COGS-to-Revenue Calculation

Daiichinkyo Co's COGS to Revenue for the fiscal year that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2789.512	/	12654.544
	=	0.22

Daiichinkyo Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	632.896	/	3479.789
	=	0.18

Daiichinkyo Co (OTCPK:DSNKY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Daiichinkyo Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	632.896 / 3479.789
	=	81.81 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Daiichinkyo Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Daiichinkyo Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (OTCPK:DSNKY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

DSKYF:USA 4568:Mexico 4568:Japan D4S:Germany

Address

3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426

Website

https://www.daiichisankyo.com

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.